Background
==========

Histopathologic analysis of biopsied specimens is an important essential diagnostic tool that is generally influenced by clinical data and other diagnostic tests. Assessing the distribution of oral and maxillofacial lesions (OMFL) is important for evaluating their prevalence in the population, and thus identifying high-risk subpopulations and optimizing health care service allocation.[@b1-ccide-11-045] Also, knowledge of the site, age, and sex predilections of different diseases of the oral cavity is useful with regard to determining their demographics.[@b2-ccide-11-045] Only few epidemiological studies on the frequency of histologically confirmed oral lesions have been conducted, primarily in the USA, India, some Asian nations, and Europe.[@b2-ccide-11-045]--[@b7-ccide-11-045] With regard to epidemiological data on oral lesions in the western region of Saudi Arabia, studies are limited, and the only published study is associated with the epidemiological outline of adolescent and pediatric lesions in the head and neck region among the population of the city of Jeddah.[@b8-ccide-11-045] Andreasen et al[@b9-ccide-11-045] reported that oral mucosal disease affects between 25% and 50% of individuals, depending on the population studied. This indicates the relatively high incidence of oral diseases in societies and necessitates intervention by local authorities to target these diseases in their communities. Therefore, the incidence and demographic characteristics of oral diseases and the oral health care needs of the population in our community should be investigated in order to develop a coherent oral health policy. In addition, such information could be useful for epidemiological and teaching purposes. The present retrospective study was conducted to describe oral lesions among 1,218 biopsies and to assess their demographic distribution in regards of age and sex. These biopsies were processed by the Oral Pathology Laboratory, Faculty of Dentistry, King Abdulaziz University, over a 20-year period.

Materials and methods
=====================

This was a retrospective study analyzing the archives of the Oral Pathology Laboratory, Faculty of Dentistry, King Abdulaziz University, Jeddah, Saudi Arabia. Data from 1,218 specimens recorded between 1996 and 2016 were retrieved from the laboratory's files, and information on sex, age, location of the lesion, and the histopathologic diagnosis were collated into a dataset and analyzed. Slides were reviewed in a blinded manner, without the reviewers knowing the original diagnoses, by two American board-certified oral and maxillofacial pathologists (NB and WE). Cases with discrepancies in diagnosis were re-examined and a consensus diagnosis was achieved. The Research Ethics Committee of the Faculty of Dentistry at King Abudulaziz University approved the study (Proposal No. 107-12-17).

Based on histologic findings obtained from the records, lesions were classified as adaptive/reactive lesions, cysts of the head and neck, bone lesions, odontogenic tumors, epithelial disorders, oral inflammation/infections, benign mesenchymal tumors, malignant tumors, immune-mediated diseases, tooth abnormalities, and salivary gland diseases. The classifications were adapted from Barnes[@b10-ccide-11-045] and Bezroukov.[@b11-ccide-11-045] Cases with inconclusive pathologic diagnoses were classified as miscellaneous.

Statistical data analysis was carried out using SPSS version 22 software. Descriptive statistics were used to outline the characteristics of the study categorical and nominal variables in the form of counts and percentages, whereas mean and SDs were determined for continuous variables.

Results
=======

A total of 1,218 histologic diagnoses over a 20-year period were analyzed in this retrospective study, with 643 (52.8%) derived from female subjects and 515 (42.3%) derived from male subjects (a female to male ratio of about 1.3). Sex was not recorded in 60 (4.9%) cases. The age of the patients ranged from 5 months to 85 years, and the mean age was 35.9 (SD ±17.9 years). [Table 1](#t1-ccide-11-045){ref-type="table"} shows the occurrence of oral lesions according to demographic factors.

Of the 1,218 diagnosed cases, 765 (62.8%) were soft tissue lesions and 453 (37.2%) were hard tissue lesions. Reactive/adaptive lesions were the most common (245; 20.1%), followed by cystic lesions (214; 17.6%), inflammatory/infectious lesions (152; 12.5%), epithelial lesions (115; 9.4%), benign mesenchymal tumors (106; 8.7%), malignant tumors (70; 5.7%), both immune-mediated diseases and salivary gland diseases and tumors (60; 4.9%), odontogenic tumors (45; 3.7%), bone lesions (30; 2.5%), pigmented lesions (16; 1.3%), and tooth abnormalities (12; 1%). Ninety-three (7.6%) miscellaneous cases had inconclusive pathologic diagnoses or were without recorded pathologic alterations. [Figure 1](#f1-ccide-11-045){ref-type="fig"} shows the percentage distribution of all OMFL by categories, while [Table 2](#t2-ccide-11-045){ref-type="table"} shows the distribution of all categories by number, age mean, and range.

In all categories, prevalence of oral and maxillofacial pathology lesion (OMFPL) in female was higher than that in male, except malignant tumors (n=39/70), epithelial lesions (n=62/115), odontogenic tumors (n=25/45), and teeth abnormalities (n=8/12), as illustrated in [Figure 2](#f2-ccide-11-045){ref-type="fig"}.

Fibroepithelial polyp was the most common lesion in the reactive group (n=65; 26.5%). Inflammatory odontogenic cyst (radicular cyst) was the most common diagnosis among all cystic types in the oral and maxillofacial area (n=134; 62.6%), while periapical granuloma was the most common inflammatory condition (n=115; 75.7%). In the benign tumor category, fibroma was the most frequently diagnosed condition (n=75; 70.8%). On the other hand, malignant lesions constituted 70/1,218 (5.8%) cases, of which squamous cell carcinoma (SCC) was the most frequent malignancy (n=46; 65.7%). The frequencies of other histopathologic diagnoses and their age and sex distributions are shown in [Table 3](#t3-ccide-11-045){ref-type="table"}.

Discussion
==========

Over 20 years, the overall number of OMFPL recorded was 1,218. The reasons for the low number of biopsies from the oral and maxillofacial region may include high dependence on clinical diagnosis and the fact that the laboratory was at an academic teaching center whereas most of the cases were referred to hospitals due to logistic considerations that restricted the reception of several cases. Also, governmental hospitals were the only external sources of cases.[@b3-ccide-11-045],[@b12-ccide-11-045] Previous studies performed in Saudi Arabia were limited and either focused on a specific age group such as children[@b8-ccide-11-045] or geriatric patients[@b13-ccide-11-045] or on specific entities such as odontogenic tumors.[@b14-ccide-11-045] Only two published studies have investigated the prevalence of OMFPLs in both northern and south western regions of Saudi Arabia.[@b15-ccide-11-045],[@b16-ccide-11-045]

Our data demonstrated a higher prevalence of OMFPL in female subjects (52.8%), and this trend has been reported in other studies. The possible explanation of this pertains to women utilizing health care more than men.[@b3-ccide-11-045],[@b17-ccide-11-045]--[@b19-ccide-11-045] However, our data differ from those of other studies reporting a high prevalence of OMFPL in male subjects in Saudi Arabia[@b12-ccide-11-045],[@b13-ccide-11-045] and other countries such as Kuwait and India.[@b2-ccide-11-045],[@b5-ccide-11-045] Specific lesions seemed to have a strong predilection for either sex. Male subjects exhibited greater incidences of malignant tumors (SCC), epithelial lesions (papilloma and epithelial dysplasia), and odontogenic tumors (ameloblastoma and odontoma), as shown in [Figure 2](#f2-ccide-11-045){ref-type="fig"}, which is consistent with a study reported by Guedes et al[@b7-ccide-11-045] in 2015.

The age of oral lesion patients in the current study ranged from 5 months to 85 years, and most were in their third, fourth, or fifth decade of life, which is consistent with previous prevalence studies.[@b15-ccide-11-045],[@b18-ccide-11-045] Only malignant lesions were more common in more advanced age (mean age 49.5 years), with the highest peak in verrucous and SCCs (mean age 65.33 and 56.65 years, respectively), as has been previously reported with regard to oral cancers.[@b2-ccide-11-045],[@b12-ccide-11-045] On the other hand, patients with the lowest age were a 5-month-old infant with a teratoma and a 2-year-old boy with pigmented neuroectodermal tumor of infancy, which were classified as benign mesenchymal and malignant lesions, respectively. Teratomas presenting in the oropharyngeal region are usually diagnosed at birth or prenatally.[@b20-ccide-11-045],[@b21-ccide-11-045] Furthermore, the pigmented or melanotic neuroectodermal tumor of infancy are diagnosed mostly within the first year of life.[@b22-ccide-11-045] Most of the OMFPLs were soft tissue lesions (n=765; 62.8%), as was also reported by Gambhir et al.[@b2-ccide-11-045] This may reflect the preference of general practitioners, residents, and specialists to perform biopsies of extraosseous oral lesions by themselves and refer intraosseous oral lesion cases to oral maxillofacial surgeons.

The frequencies and types of OMFPL varied, but reactive/adaptive lesions were the most common in the present study and several previous studies.[@b3-ccide-11-045],[@b5-ccide-11-045],[@b13-ccide-11-045],[@b18-ccide-11-045] Fibroepithelial polyp was the most common diagnosis in this category (26.5%), with a mean patient age of 41.7 years. A similar study showed the highest prevalence of traumatic fibroma (fibroepithelial polyp) among reactive lesions (37.4%) mainly in patients in their third to fourth decade.[@b23-ccide-11-045] Cystic lesions were the second most common, and the most prevalent inflammatory odontogenic cysts were radicular cysts in the current study, followed by dentigerous cysts as developmental odontogenic cysts, and this is concordant with Fierro-Garibay et al.[@b24-ccide-11-045] In a study conducted in Saudi Arabia by Luqman and Al Shabab[@b12-ccide-11-045] investigating inflammatory lesions -- which were the third most common lesions diagnosed in our study -- the majority of their 267 specimens were diagnosed as periapical granuloma. However, periapical granulomas were the second most common lesions diagnosed in our study, with 115 cases (9.4% of all specimens), and radicular cysts were the most commonly diagnosed inflammatory condition (n=134; 11%), which was classified as cyst in our study.

Fibroma was the most common benign mesenchymal tumor, which is concordant with other studies.[@b5-ccide-11-045],[@b18-ccide-11-045] Lesions related to immune-mediated diseases were observed in 60 (4.9%) specimens and were more common in female subjects (70%), and the mean age of patients with these conditions was 44.4 years. In the present study, salivary gland lesions were grouped into salivary gland disease, benign and malignant tumors. Mucocele, pleomorphic adenoma, and adenoid cystic carcinoma were the most common diagnoses in each respective subgroup. The overall prevalences of immune-mediated diseases and salivary gland lesions in this study were comparable to that of previous studies.[@b4-ccide-11-045],[@b15-ccide-11-045],[@b17-ccide-11-045]

The rate of malignant lesions in this study (5.8%) was lower than the previously reported prevalence in Kuwait which reported only 6.5% of SCC.[@b5-ccide-11-045] Surprisingly, studies from the south western region of Saudi Arabia reported a much higher incidence of malignant (38.8%) compared to benign (10.9%) neoplasms.[@b16-ccide-11-045],[@b25-ccide-11-045] This rise in malignancy was due to a major increase in SCC incidence (36.1%) with a strong female predilection (F:M ratio =1:2.2). Smokeless tobacco, specifically Shamma, was held accountable for this rise in SCC incidence in that region, as \>45% of SCC patients were Shamma users.[@b16-ccide-11-045] In the current study, SCC was the most common of all malignancies of the head and neck area; it was more common in male subjects, and the mean age of patients with this condition was 56.7 years, which is in agreement with most other retrospective studies.[@b3-ccide-11-045],[@b5-ccide-11-045],[@b13-ccide-11-045],[@b19-ccide-11-045] On the other hand, the frequency of malignant lesions in the current study was higher than that reported in studies by Jones and Franklin,[@b3-ccide-11-045] Moridani et al,[@b18-ccide-11-045] and Mendez et al,[@b19-ccide-11-045] in which they accounted for 5.4%, 2.4%, and 1.9% of cases, respectively. The frequency of diagnosis of SCC (n=46; 3.7%) was higher than the frequency of diagnosis of epithelial dysplasia (n=31; 2.5%) in the oral cavity. This was also the case in other regions of Saudi Arabia, as only 3.6% and 2.7% of OMFPLs were dysplastic in comparison to 4.7% and 38.8% of SCC cases in both northern and south western regions, respectively.[@b15-ccide-11-045],[@b16-ccide-11-045] This suggests failure of early detection of suspicious oral lesions by oral health care providers, delay of case referral from general dental practitioners to biopsy the lesions, or patients being unaware of oral cancer lesions and not seeking treatment in the absence of pain. Demographic data such as socioeconomic status, location, occupation, and oral habits that can help to identify risk groups were not comprehensively recorded in the pathology reports or requisition forms. Thus, unfortunately, we were unable to evaluate these parameters in the present study. The potential value of such information with regard to understanding the characteristics of OMFL in our population should be emphasized to oral health care providers.

Conclusion
==========

The present study yielded data on the frequency of OMFPL observed in a Saudi population presenting at an academic center in the western region of Saudi Arabia. The data constitute baseline information pertaining to epidemiologic aspects of OMFPLs that may be useful in further studies. The most commonly diagnosed OMFPLs were benign. Even when the difficulties in comparing prevalence rates from other studies are taken into account, the results of the present study are in substantial agreement with reported data in previous studies.[@b5-ccide-11-045],[@b18-ccide-11-045]
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###### 

Demographic patient data

  Variables      Number      Minimum    Maximum    Mean         SD
  -------------- ----------- ---------- ---------- ------------ ------------
  Age            1,218       5 months   85 years   35.9 years   17.9 years
                 **Count**   **%**                              
                 Total       1,218      100.0                   
  Sex            Male        515        42.3                    
  Female         643         52.8                               
  Unidentified   60          4.9                                

###### 

Number of diagnoses by category (1996--2016)

  Diagnostic category                                                     Number of cases   Mean age   SD     Age range (years)
  ----------------------------------------------------------------------- ----------------- ---------- ------ --------------------
  Reactive/adaptive[a](#tfn1-ccide-11-045){ref-type="table-fn"}           245               37.16      17.4   5--85
  Cystic[a](#tfn1-ccide-11-045){ref-type="table-fn"}                      214               31.83      15.4   5--85
  Inflammatory[a](#tfn1-ccide-11-045){ref-type="table-fn"}                152               31.48      15.6   6--75
  Epithelial lesions[a](#tfn1-ccide-11-045){ref-type="table-fn"}          115               44.08      17.4   5--84
  Benign mesenchymal tumors[a](#tfn1-ccide-11-045){ref-type="table-fn"}   106               41.35      19.1   5 months--77 years
  Miscellaneous[a](#tfn1-ccide-11-045){ref-type="table-fn"}               93                30.6       22.0   4--72
  Malignant tumors                                                        70                49.52      20.7   2--85
  Immune-mediated diseases[a](#tfn1-ccide-11-045){ref-type="table-fn"}    60                44.38      13.0   16--62
  Salivary gland diseases and tumors                                      60                27.30      16.2   5--65
  Odontogenic tumors[a](#tfn1-ccide-11-045){ref-type="table-fn"}          45                25.46      14.8   9--68
  Bone[a](#tfn1-ccide-11-045){ref-type="table-fn"}                        30                31.25      19.9   2.5--81
  Pigmented[a](#tfn1-ccide-11-045){ref-type="table-fn"}                   16                37.13      13.6   19--65
  Tooth abnormalities                                                     12                23.25      11.4   9--41
  Total                                                                   1,218                               

**Note:**

Sex of some patients was unknown.

###### 

Histopathologic diagnoses in each category

  Diagnosis                                                                      Number    Male   Female   M:F ratio   Mean age (years)   SD
  ------------------------------------------------------------------------------ --------- ------ -------- ----------- ------------------ -------
                                                                                                                                          
  **Reactive/adaptive**                                                          **245**                                                  
  Fibroepithelial polyp[a](#tfn2-ccide-11-045){ref-type="table-fn"}              65        19     42       0.45        41.70              16.93
  Pyogenic granuloma[a](#tfn2-ccide-11-045){ref-type="table-fn"}                 63        29     33       0.88        34.45              16.91
  Nonspecific inflammation[a](#tfn2-ccide-11-045){ref-type="table-fn"}           58        29     26       1.12        37.49              17.78
  Scar and fibrosis[a](#tfn2-ccide-11-045){ref-type="table-fn"}                  26        9      16       0.56        35.88              16.00
  Inflammatory fibrous hyperplasia[a](#tfn2-ccide-11-045){ref-type="table-fn"}   14        5      8        0.57        43.21              21.93
  Peripheral ossifying fibroma                                                   5         3      4        0.75        34.20              14.92
  Plasma cell gingivitis[a](#tfn2-ccide-11-045){ref-type="table-fn"}             5         0      4        0           33.50              9.26
  Gingival polyp                                                                 3         0      3        0           14.33              2.52
  Peripheral giant cell granuloma                                                3         1      2        0.50        47.00              19.80
  Hamartoma                                                                      1         1      0                    49                 0
  Xanthogranuloma                                                                1         1      0                    27                 0
  Submucous fibrosis                                                             1         0      1        0           45                 0
                                                                                                                                          
  **Cystic**                                                                     **214**                                                  
                                                                                                                                          
  Inflammatory odontogenic cyst                                                                                                           
   Radicular and residual cysts                                                  134       65     62       1.0         32.1               14.6
  Developmental odontogenic cyst                                                                                                          
   Dentigerous cyst                                                              38        19     17       1.1         28.2               13.5
   Odontogenic keratocyst                                                        17        9      8        1.1         35.8               16.4
   Gorlin cyst                                                                   2         0      2        0.0         20.5               7.8
   Glandular odontogenic cyst                                                    3         1      2        0.5         71.5               19.1
   Lateral periodontal cyst                                                      1         0      1        0           35.0               0
  Non-odontogenic cyst                                                                                                                    
   Traumatic bone cyst                                                           7         2      5        0.4         38.4               16.41
   Antral cyst                                                                   3         1      2        0.5         34                 1.73
   Nasolabial cyst                                                               2         0      2        0           41                 11.31
   Oral lymphoepithelial cyst                                                    2         1      1        1           49                 2.83
   Median palatal cyst                                                           1         1      0                    24                 0
   Sebaceous cyst                                                                1         1      0                    52                 0
   Thyroglossal tract cyst                                                       1         0      1        0           13                 0
   Dermoid cyst                                                                  1         0      1        0           25                 0
   Nasopalatine duct cyst                                                        1         1      0                    55                 0
                                                                                                                                          
  **Inflammatory**                                                               **152**                                                  
                                                                                                                                          
  Periapical granuloma or abscess[a](#tfn2-ccide-11-045){ref-type="table-fn"}    115       37     63       0.59        31.10              14.56
  Pulp diseases                                                                  14        4      10       0.40        22                 14.43
  Osteomyelitis                                                                  10        4      6        0.67        47.22              21.05
  Infectious conditions                                                          7         2      5        0.40        35.67              9.93
  Sinus conditions                                                               6         4      2        2.00        31.83              14.08
                                                                                                                                          
  **Epithelial**                                                                 **115**                                                  
                                                                                                                                          
  Hyperkeratosis and acanthosis[a](#tfn2-ccide-11-045){ref-type="table-fn"}      66        36     27       1.33        45.09              15.62
  Epithelial dysplasia                                                           31        16     15       1.07        53.71              15.05
  Papilloma                                                                      14        7      7        1           19.50              14.54
  Smokeless tobacco lesion                                                       3         3      0        0           42                 12.17
  Verruca vulgaris                                                               1         0      1                    14                 0
                                                                                                                                          
  **Benign mesenchymal**                                                         **106**                                                  
                                                                                                                                          
  Fibroma                                                                        75        27     43       0.63        44.97              16.33
  Vascular tumor                                                                 7         5      2        2.50        35.67              26.85
  Lipoma                                                                         6         1      5        0.20        50.50              13.20
  Leiomyoma                                                                      3         1      2        0.50        11.33              8.39
  Neurofibroma                                                                   4         1      3        0.33        31.75              20.84
  Fibrous histiocytoma                                                           3         1      2        0.50        28.33              10.12
  Teratoma                                                                       1         0      1        0           5 months           0
  Myofibroma                                                                     1         1      0                    4                  0
  Osteoma                                                                        1         1      0                    20                 0
  Inflammatory myofibroblastic tumor                                             1         0      1        0           10                 0
  Traumatic neuroma                                                              1         0      1        0                              
  Plasma cell myeloma                                                            1         1      0                    66                 0
  Granular cell tumor                                                            1         1      0                    48                 0
  Myxoma                                                                         1         1      0                    42                 0
                                                                                                                                          
  **Malignancies**                                                               **70**                                                   
                                                                                                                                          
  Squamous cell carcinoma                                                        46        27     19       1.42        56.65              16.62
  Langerhans cell histiocytosis                                                  10        7      3        2.33        32.60              17
  Verrucous carcinoma                                                            4         2      2        1           67.75              8.99
  Lymphoma                                                                       3         0      3        0           41.67              21.50
  Nasopharyngeal carcinoma                                                       1         0      1        0           76                 0
  Fibrosarcoma                                                                   1         1      0        0           17                 0
  Round blue cell sarcoma                                                        1         0      1        0           19                 0
  Osteosarcoma                                                                   1         0      1        0           20                 0
  Pigmented neuroectodermal tumor of infancy                                     1         1      0                    2                  0
  Rhabdomyosarcoma                                                               1         0      1                    51                 0
  Undifferentiated neoplasm                                                      1         1      0                    40                 0
                                                                                                                                          
  **Immune-mediated disease**                                                    **60**                                                   
                                                                                                                                          
  Lichen planus[a](#tfn2-ccide-11-045){ref-type="table-fn"}                      54        12     39       0.31        44.70              12.96
  Pemphigus                                                                      6         3      3        1           42                 14.28
                                                                                                                                          
  **Salivary gland**                                                             **60**                                                   
                                                                                                                                          
  Malignant                                                                                                                               
   Adenoid cystic adenocarcinoma                                                 3         2      1        2           48.67              8.49
   Mucoepidermoid carcinoma                                                      2         0      2        0           45                 14.14
   Polymorphous low-grade adenocarcinoma                                         1         1      0                    19                 0
   Carcinoma ex pleomorphic adenoma                                              1         0      1        0           42                 0
   Adenocarcinoma not otherwise specified                                        1         0      1        0           27                 0
   Basal cell adenocarcinoma                                                     1         0      1        0                              
  Benign                                                                                                                                  
   Pleomorphic adenoma                                                           5         3      2        1.5         36.5               13.48
   Warthin's tumor                                                               1         1      0                    53                 0
  Salivary gland diseases                                                                                                                 
   Mucocele[a](#tfn2-ccide-11-045){ref-type="table-fn"}                          34        16     19       0.84        18.59              10.88
   Retention cyst[a](#tfn2-ccide-11-045){ref-type="table-fn"}                    3         0      2        0           56.67              34.21
   Necrotizing sialometaplasia                                                   3         2      1        2           49.67              16.04
   Ranula                                                                        2         0      2        0           9                  2.83
   Sialolithiasis                                                                1         0      1        0           47                 0
   Chronic sialadenitis                                                          1         0      1        0           35                 0
   Chronic sclerosing polycystic adenosis                                        1         1      0                    12                 0
                                                                                                                                          
  **Odontogenic tumor**                                                          **45**                                                   
                                                                                                                                          
  Ameloblastoma[a](#tfn2-ccide-11-045){ref-type="table-fn"}                      21        13     7        1.86        24.50              12.15
  Odontoma[a](#tfn2-ccide-11-045){ref-type="table-fn"}                           17        9      7        1.29        23.07              15.06
  Adenomatoid odontogenic tumor                                                  2         1      1        1           22.5               7.78
  Ameloblastic fibroma                                                           2         1      1        1           22                 7.07
  Calcifying epithelial odontogenic tumor                                        2         0      2        0           47                 0
  Ameloblastic carcinoma                                                         1         1      0        0           68                 0
                                                                                                                                          
  **Bone**                                                                       **30**                                                   
                                                                                                                                          
  Benign fibro-osseous lesions[a](#tfn2-ccide-11-045){ref-type="table-fn"}       24        10     13       0.77        27.58              17.91
  Giant cell lesions                                                             4         3      1        3           30                 8.12
  Osteonecrosis                                                                  2         0      2        0           70.5               14.85
                                                                                                                                          
  **Pigmented**                                                                  **16**                                                   
                                                                                                                                          
  Nevus (intradermal/intercostal)                                                7         2      2        1           32.14              7.88
  Melanotic macule                                                               4         0      4        0           51.75              11.30
  Racial pigmentation[a](#tfn2-ccide-11-045){ref-type="table-fn"}                2         0      1        0           19                 0.00
  Amalgam tattoo                                                                 2         1      1        1           43                 11.31
  Melanoacanthoma                                                                1         0      1        0           20                 0
                                                                                                                                          
  **Teeth abnormalities**                                                        12        8      4        2           23.25              11.41
                                                                                                                                          
  **Miscellaneous**                                                              93        34     50       31.85       22.01              24.5

**Note:**

Undetermined sex in some cases.
